Announcements
- Cardlytics Announces First Quarter 2024 Financial Results
- Cardlytics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Cardlytics Announces Timing of Its First Quarter 2024 Earnings Release
- Liane Hornsey Appointed to Cardlytics Board of Directors
- Cardlytics Prices $150.0 Million Convertible Senior Notes Offering
- Cardlytics Announces Proposed Convertible Senior Notes Offering
- Cardlytics Announces Fourth Quarter and Full Year 2023 Financial Results
- Cardlytics Announces Timing of Its Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast
- Cardlytics Announces Successful Resolution of SRS Dispute and Preliminary Fourth Quarter 2023 Results
- Cardlytics Appoints Two New Members to its Board of Directors
More ▼
Key statistics
As of last trade, Cardlytics (CDLX*:MEX) traded at 159.87, 48.85% above the 52 week low of 107.40 set on Jan 24, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 146.10 |
Average volume | 0.00 |
---|---|
Shares outstanding | 48.78m |
Free float | 46.11m |
P/E (TTM) | -- |
Market cap | 427.83m USD |
EPS (TTM) | -4.42 USD |
Data delayed at least 20 minutes, as of Jan 24 2024 11:30 GMT.
More ▼